Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-01 @ 7:43 PM
Study NCT ID:
NCT00710866
Status:
COMPLETED
Last Update Posted:
2011-08-04
First Post:
2008-07-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity
Sponsor:
British Columbia Centre for Disease Control
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TITRE
Brief Summary:
The purpose of this study is to compare the antibody response and reaction rates in children age 6-23 months when they are given either the currently recommended schedule of two 0.25ml doses of influenza vaccine one month apart or two 0.5ml doses of influenza vaccine, one month apart.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: